Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade

Catheterization and Cardiovascular Interventions

Volumn 66, Issue 2, 2005, Pages 149-157

  Levine, Glenn N ^a,i   Lincoff, A Michael ^b   Ferguson III, James J ^c   Mahaffey, Kenneth W ^d   Goodman, Shaun G ^e   Cannon, Christopher P ^f   Theroux, Pierre ^g   Fox, Keith A A ^h  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g MONTREAL HEART INSTITUTE   (Canada)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Management; Non ST segment elevation acute coronary syndrome

Indexed keywords

CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; HEPARIN; PLACEBO; SIMVASTATIN;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DECISION MAKING; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION; SYSTEMATIC REVIEW; UNITED STATES;

ACUTE DISEASE; ANGINA, UNSTABLE; HEART CATHETERIZATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; REGISTRIES;

EID: 26644457434     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20469     Document Type: Article

References (28)

1. GUSTO IIb investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335:775-782.
2. Fu Y, Chang WC, Mark D, Califf RM, Mackenzie B, Granger CB, et al. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Circulation 2000; 102:1375-1381.
3. PURSUIT trial investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes: platelet glycoprotein iib/iiia in unstable angina-receptor suppression using integrilin therapy. N Engl J Med 1998; 339:436-443.
4. Lincoff AM, Harrington RA, Califf RM, Hochman JS, Guerci AD, Ohman EM, et al. Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition: insights from the platelet glycoprotein IIb/IIIa in unstable angina-receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 2000;102:1093-1100.
5. PARAGON-B investigators. Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes. Circulation 2002;105:316-321.
6. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
7. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS. Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-533.
8. Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, et al. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA 2004;292:55-64.
9. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004; 292:45-54.
10. Yusuf S, Flather M, Pogue J, Hunt D, Varigos J, Piegas L, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation: OASIS registry investigators. Lancet 1998;352:507-514.
11. Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, et al. Differences between men and women in the management of unstable angina pectoris (the GUARANTEE registry). Am J Cardiol 1999;84:1145-1150.
12. Collinson J, Flather MD, Fox KA, Findlay I, Rodrigues E, Dooley P, et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000;21:1450-1457.
13. Fox KA, Goodman SG, Anderson FA Jr, Granger CB, Moscucci M, Flather MD, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes - the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1414-1424.
14. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean Basin: the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23:1190-1201.
15. Zia M, Goodman SG, Roe MT, et al. Paradoxical utilization of invasive cardiac procedures for patients with non-ST-segment elevation myocardial infarction: an American-Canadian comparison form the CRUSADE initiative and Canadian registries. J Am Coll Cardiol 2004;43(Suppl A):276A.
16. Roe MT, Parsons L, Pollack C, Canto JG, Barron HV, Every N, et al. Disparities in the treatment of acute myocardial infarction: underutilization of evidence-based therapies for patients with non-ST-segment myocardial infarction. J Am Coll Cardiol 2004;41(Suppl A):540A-541A.
17. Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah S, Antman EM. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol 2004;93:830-835.
18. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
19. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet 2002;360:743-751.
20. FRISC II investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-715.
21. Berger PB, Steinhubl S. Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspective. Circulation 2002;106:2284-2287.
22. PRISM-PLUS study investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338: 1488-1497.
23. Kongo RH, Ley J, Dick SE, Yee RR. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002;40:231-237.
24. Levine GN, Kern MJ, Berger PB, Brown DL, Klein LW, Kereiakes DJ, et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 2003;139:123-136.
25. Herlitz J, McGovern P, Dellborg M, Karlsson T, Duval S, Karlson BW, et al. Comparison of treatment and outcomes for patients with acute myocardial infarction in Minneapolis/St. Paul, Minnesota, and Goteborg, Sweden. Am Heart J 2003;146: 1023-1029.
26. Van de WF, Topol EJ, Lee KL, Woodlief LH, Granger CB, Armstrong PW, et al. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries: results from the GUSTO trial. JAMA 1995; 273:1586-1591.
27. Tu JV, Pashos CL, Naylor CD, Chen E, Normand SL, Newhouse JP, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336:1500-1505.
28. Fox KA, Goodman S, Bigonzi F, Le L, V, Cohen M. Interregional differences and outcome in unstable angina: analysis of the international ESSENCE trial. Eur Heart J 2000;21:1433-1439.